12853352

Source:http://linkedlifedata.com/resource/pubmed/id/12853352

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0282460, umls-concept:C1140680
pubmed:issue	7
pubmed:dateCreated	2003-7-10
pubmed:abstractText	This multicenter, prospective phase II study evaluated the safety and efficacy of the combination of docetaxel and vinorelbine in patients with platinum-resistant, paclitaxel-pretreated recurrent ovarian cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0923-7534
pubmed:author	pubmed-author:AravantinosGG, pubmed-author:BafaloukosDD, pubmed-author:ChristodoulouCC, pubmed-author:DimopoulosM AMA, pubmed-author:FountzilasGG, pubmed-author:GogasHH, pubmed-author:KalofonosH PHP, pubmed-author:KosmidisPP, pubmed-author:PapadimitriouCC, pubmed-author:PavlidisNN
pubmed:issnType	Print
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1094-9
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:12853352-Adult, pubmed-meshheading:12853352-Aged, pubmed-meshheading:12853352-Antineoplastic Agents, pubmed-meshheading:12853352-Antineoplastic Agents, Phytogenic, pubmed-meshheading:12853352-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12853352-Cisplatin, pubmed-meshheading:12853352-Disease Progression, pubmed-meshheading:12853352-Disease-Free Survival, pubmed-meshheading:12853352-Drug Resistance, Neoplasm, pubmed-meshheading:12853352-Female, pubmed-meshheading:12853352-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:12853352-Humans, pubmed-meshheading:12853352-Leukopenia, pubmed-meshheading:12853352-Middle Aged, pubmed-meshheading:12853352-Neoplasm Recurrence, Local, pubmed-meshheading:12853352-Neutropenia, pubmed-meshheading:12853352-Ovarian Neoplasms, pubmed-meshheading:12853352-Paclitaxel, pubmed-meshheading:12853352-Prospective Studies, pubmed-meshheading:12853352-Taxoids, pubmed-meshheading:12853352-Treatment Outcome, pubmed-meshheading:12853352-Vinblastine
pubmed:year	2003
pubmed:articleTitle	Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
pubmed:affiliation	Hellenic Co-operative Oncology Group, Athens, Greece. hecogaga@otenet.gr
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study, Clinical Trial, Phase II